See more : Persimmon Plc (PSN.L) Income Statement Analysis – Financial Results
Complete financial analysis of DSwiss, Inc. (DQWS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of DSwiss, Inc., a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Insperity, Inc. (NSP) Income Statement Analysis – Financial Results
- Kenedix Residential Next Investment Corporation (3278.T) Income Statement Analysis – Financial Results
- FlexiInternational Software Inc. (FLXI) Income Statement Analysis – Financial Results
- Rimbunan Sawit Berhad (5113.KL) Income Statement Analysis – Financial Results
- Life Settlement Assets PLC (LSAA.L) Income Statement Analysis – Financial Results
DSwiss, Inc. (DQWS)
Industry: Household & Personal Products
Sector: Consumer Defensive
Website: https://www.dswissbeauty.com
About DSwiss, Inc.
DSwiss, Inc., a biotech-nutraceutical company, supplies health and beauty products in Malaysia, Singapore, Indonesia, Taiwan, Macau, Hong Kong, and China. Its products include DSwiss coffee for digestive health; DSwiss kiwi, which helps the body's immune system, as well as enhances skin complexion, reduces blood pressure, and prevents heart disease and stroke; DSwiss Triple SC that focuses on stem cells; DSwiss silk mask, a mask for dry, damaged, and sensitive skin; DSwiss coffee slimming scrub, a natural body scrub for removing dirt on the skin layers; DSwiss peppermint slimming gel, a cooling agent; DSwiss new age essence delivers nutrients to moisten, brighten, and revive tired looking skin; and DSwiss enlighten essence cream, a light and nourishing cream. The company also provides DSwiss BioSpec, a medical eye-wear; Genmune-Pro, a product that helps the human's immunity system through enhancing the digestive health; SkinEra, a skin solution for acne, pimples, atopic dermatitis, dry skin, and allergy rashes; SensiBath gel; SuiSu hand purifiers and sanitizers, and air sanitizers; and MasterLiv to help support liver health, MasterHeart to help maintain optimum heart health and smooth blood circulation, and WellG, which offers nutrients needed for the metabolism of sugar and energy production. In addition, it provides DSwiss quantum magnetic analyzer, an equipment that reads and analyzes body energy field to test the health status and suggest recommendations; and AI skin analyzer machine, a facial camera for facial skin image data, as well as turnkey private label manufacturing services. Further, the company offers medical consumables, including surgical gowns and gloves, 3-ply face masks, N95 masks, protective goggles, body infrared thermometers, disposable bedsheets, and stretcher covers; and DNA microarray genotyping services. DSwiss, Inc. was incorporated in 2015 and is headquartered in Kuala Lumpur, Malaysia.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.47M | 1.85M | 1.96M | 1.35M | 273.66K | 220.12K | 181.40K | 137.18K | 154.97K | 458.29K | 520.61K |
Cost of Revenue | 1.11M | 1.40M | 1.46M | 980.24K | 181.93K | 178.29K | 36.03K | 64.94K | 83.93K | 194.15K | 190.34K |
Gross Profit | 359.23K | 444.99K | 499.12K | 367.48K | 91.73K | 41.83K | 145.37K | 72.25K | 71.04K | 264.14K | 330.27K |
Gross Profit Ratio | 24.44% | 24.07% | 25.48% | 27.27% | 33.52% | 19.00% | 80.14% | 52.66% | 45.84% | 57.64% | 63.44% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 410.75K | 444.72K | 353.17K | 333.31K | 290.23K | 0.00 | 0.00 | 170.20K | 102.02K | 202.74K | 249.37K |
Selling & Marketing | -43.10K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 224.67K | -21.88K | 22.60K | 19.87K |
SG&A | 367.65K | 444.72K | 353.17K | 333.31K | 290.23K | 236.65K | 204.55K | 394.87K | 80.14K | 225.34K | 269.24K |
Other Expenses | 0.00 | 1.30K | 1.46K | 1.22K | 151.08K | -184.58K | 966.00 | 13.00 | 107.00 | 0.00 | 0.00 |
Operating Expenses | 367.65K | 446.03K | 354.64K | 334.52K | 441.31K | 421.23K | 204.55K | 394.87K | 80.14K | 246.48K | 284.46K |
Cost & Expenses | 1.52M | 1.85M | 1.81M | 1.31M | 623.24K | 599.52K | 240.58K | 459.80K | 164.06K | 440.62K | 474.80K |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.06K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 2.92K | 6.21K | 2.60K | 2.81K | 2.45K | 8.06K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 65.96K | 73.47K | 66.42K | 63.62K | 65.53K | 24.82K | 27.16K | 20.25K | 18.65K | 20.64K | 14.09K |
EBITDA | 20.00K | 77.26K | 219.29K | 201.55K | -227.48K | -346.53K | -258.69K | -495.77K | -110.78K | 38.30K | 59.90K |
EBITDA Ratio | 1.36% | 4.18% | 11.20% | 14.95% | -80.56% | -161.09% | -17.65% | -220.42% | 6.16% | 8.36% | 11.51% |
Operating Income | -52.86K | 3.79K | 152.88K | 137.93K | -285.98K | -379.40K | -59.18K | -322.62K | -9.10K | 17.66K | 45.81K |
Operating Income Ratio | -3.60% | 0.21% | 7.81% | 10.23% | -104.50% | -172.36% | -32.62% | -235.18% | -5.87% | 3.85% | 8.80% |
Total Other Income/Expenses | 3.99K | -1.39K | 5.79K | -2.91K | -2.20K | -38.39K | -59.16K | -23.20K | -120.22K | -21.14K | -15.22K |
Income Before Tax | -48.88K | -2.42K | 150.28K | 30.05K | -295.46K | -371.35K | -284.89K | -516.02K | -129.32K | 17.66K | 45.81K |
Income Before Tax Ratio | -3.32% | -0.13% | 7.67% | 2.23% | -107.97% | -168.70% | -157.05% | -376.16% | -83.45% | 3.85% | 8.80% |
Income Tax Expense | 657.00 | 516.00 | 176.00 | 2.87K | 56.48K | 16.12K | 966.00 | -1.03M | -26.00 | 424.00 | 1.09K |
Net Income | -49.54K | -14.29K | 173.46K | 27.18K | -351.94K | -351.31K | -284.38K | -508.07K | -129.29K | 17.24K | 44.72K |
Net Income Ratio | -3.37% | -0.77% | 8.86% | 2.02% | -128.61% | -159.60% | -156.77% | -370.36% | -83.43% | 3.76% | 8.59% |
EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Weighted Avg Shares Out | 206.90M | 206.90M | 206.90M | 206.90M | 206.90M | 206.90M | 206.43M | 203.46M | 205.34M | 206.90M | 206.90M |
Weighted Avg Shares Out (Dil) | 206.90M | 206.90M | 206.90M | 206.90M | 206.90M | 206.90M | 206.43M | 203.46M | 205.34M | 206.90M | 206.90M |
Source: https://incomestatements.info
Category: Stock Reports